Emerging as a hybrid imaging modality, cone-beam X-ray luminescence computed tomography (CB-XLCT) has been developed using X-ray-excitable nanoparticles. In contrast to conventional bio-optical imaging techniques like bioluminescence tomography (BLT) and fluorescence molecular tomography (FMT), CB-XLCT offers the advantage of greater imaging depth while significantly reducing interference from autofluorescence and background fluorescence, owing to its utilization of X-ray-excited nanoparticles. However, due to the intricate excitation process and extensive light scattering within biological tissues, the inverse problem of CB-XLCT is fundamentally ill-conditioned.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: